| Dokumendiregister | Sotsiaalministeerium |
| Viit | 2-6.4/2105-1 |
| Registreeritud | 02.09.2026 |
| Sünkroonitud | 03.09.2026 |
| Liik | Väljaminev kiri |
| Funktsioon | 2 Välisabi ja struktuuritoetuste rakendamine |
| Sari | 2-6.4 Norra / EMP finantsinstrument 2021-2028 |
| Toimik | 2-6.4/26842 |
| Juurdepääsupiirang | Avalik |
| Adressaat | Riigi Tugiteenuste Keskus |
| Saabumis/saatmisviis | Riigi Tugiteenuste Keskus |
| Vastutaja | Ülar Vaadumäe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Innovatsiooni vastutusvaldkond, Välisvahendite osakond) |
| Originaal | Ava uues aknas |
| Taotle dokumendi eemaldamist või parandamist |
Suur-Ameerika 1 / 10122 Tallinn / 626 9301 / [email protected] / www.sm.ee / Registrikood 70001952
Pärt-Eo Rannap Riigi Tugiteenuste Keskus [email protected] Lõkke 4 10122, Tallinn
Teie 26.05.2026 Meie 02.09.2026 nr 2-6.4/2105-1
Euroopa Majanduspiirkonna toetustest 2021–2028 rahastatud programmi "Rahvatervis" finantsvahearuanne nr 1 Lugupeetud Pärt-Eo Rannap Edastame Teile Euroopa Majanduspiirkonna toetustest 2021–2028 rahastatud programmi "Rahvatervis" finantsvahearuande nr 1. Kinnitame, et programmi rakendamine toimub vastavuses Euroopa Majanduspiirkonna toetuste 2021–2028 rakendusmääruse ja siseriikliku seadusandlusega. Aruandeperioodil kulusid ei tekkinud. Lugupidamisega (allkirjastatud digitaalselt) Nele Labi asekantsler Lisa: Finantsvahearuanne nr 1 Ülar Vaadumäe [email protected]
Version 0.2 as of 14/08/2026 15:02:21 CEST 1
Interim financial report EEA Financial Mechanisms 2021-2028 Interim financial report number 1 Programme summary
Programme operator Ministry of Social Affairs - Estonia Beneficiary State Estonia Programme title Public Health Programme code EE-HEALTH Eligible Expenditure € 14,414,411.77 Programme grant rate 100.00 % Programme grant amount € 12,265,000.00 EEA Grant Amount € 12,265,000.00 Norway Grant Amount € 0.00 Start date of eligibility 28/05/2025 Final date of eligibility 30/04/2032
Version 0.2 as of 14/08/2026 15:02:21 CEST 2
Part A - Statement of expenditure declared and interest earned/paid
Declared expenditure - summary Interim financial report number 1 Start date of declared expenditure period 28/05/2025 End date of declared expenditure period 30/06/2026
Previously declared expenditure
Declared expenditure for the period
Total declared to date
Total budget Available budget
Eligible expenditure € 0.00 € 0.00 € 0.00 € 14,414,411.77 € 14,414,411.77
EEA Grants € 0.00 € 0.00 € 0.00 € 12,265,000.00 € 12,265,000.00 Co-financing € 0.00 € 0.00 € 0.00 € 2,149,411.77 € 2,149,411.77
Declared expenditure - details Title: Programme management Brief description of declared expenditure
No costs occurred yet.
Eligible expenditures Eligible expenditure - EUR
€ 0.00 Total
€ 0.00
Title: Outcome 1: Enhanced prevention of risk-behaviours (EEA Grants) Brief description of declared expenditure
No costs occurred yet.
Title: Outcome 2: Enhanced evidence to improve responses to domestic and gender-based violence (EEA Grants) Brief description of declared expenditure
No costs occurred yet.
Title: Outcome 3: Improved integration of patient-centred care (EEA Grants) Brief description of declared expenditure
No costs occurred yet.
Title: Outcome 4: Genomic Medicine integrated into public health and clinical practice (EEA Grants) Brief description of declared expenditure
No costs occurred yet.
Title: Bilateral Outcome: Bilateral funds at programme level Brief description of declared expenditure
No costs occurred yet.
Eligible expenditures Eligible expenditure - EUR
€ 0.00 Total
€ 0.00
Version 0.2 as of 14/08/2026 15:02:21 CEST 3
Interest earned Interest paid on accounts established by the Programme Operator for funds intended for regranting in the current reporting period.
EEA Grants Total € 0.00 € 0.00
Cumulative interest generated on accounts established by the Programme Operator for funds intended for regranting.
EEA Grants Total € 0.00 € 0.00
Interest paid Interest generated on accounts established by the Programme Operator for funds intended for regranting in the current reporting period.
EEA Grants Total € 0.00 € 0.00
Cumulative interest paid on accounts established by the Programme Operator for funds intended for regranting.
EEA Grants Total € 0.00 € 0.00
Comment No costs occurred yet.
Version 0.2 as of 14/08/2026 15:02:21 CEST 4
Part B - Statement of expenditure proposed
Proposed expenditure - summary Start date of proposed expenditure period 01/01/2027 End date of proposed expenditure period 30/06/2027
Previous advance and interim payments
Proposed expenditure for the period
Total to date Total budget Available budget
Eligible expenditure € 0.00 € 610,000.00 € 610,000.00 € 14,414,411.77 € 13,804,411.77
EEA Grants € 0.00 € 519,250.00 € 519,250.00 € 12,265,000.00 € 11,745,750.00 Co-financing € 0.00 € 90,750.00 € 90,750.00 € 2,149,411.77 € 2,058,661.77
Title: Programme management Brief description of declared expenditure PO project coordinator salary, Implementation Agency salaries, programme opening event, cooperation committee meetings.
Previous advance and interim payments
Proposed expenditure for the period
Total to date Total budget Available budget
Eligible expenditure € 0.00 € 70,000.00 € 70,000.00 € 1,309,008.24 € 1,239,008.24
* For management costs it is not possible to request more than € 1,178,107.42 of the total amount as 10.00 % is retained for the programme closure. Title: Outcome 1: Enhanced prevention of risk-behaviours (EEA Grants) Brief description of declared expenditure Payments to pre-defined project No 1
Previous advance and interim payments
Proposed expenditure for the period
Total to date Total budget Available budget
Eligible expenditure € 0.00 € 180,000.00 € 180,000.00 € 6,229,815.29 € 6,049,815.29
Title: Outcome 2: Enhanced evidence to improve responses to domestic and gender-based violence (EEA Grants) Brief description of declared expenditure Payments to pre-defined project No 1 Title: Outcome 3: Improved integration of patient-centred care (EEA Grants) Brief description of declared expenditure Payments to pre-defined project No 2
Previous advance and interim payments
Proposed expenditure for the period
Total to date Total budget Available budget
Eligible expenditure € 0.00 € 175,000.00 € 175,000.00 € 2,791,764.71 € 2,616,764.71
Title: Outcome 4: Genomic Medicine integrated into public health and clinical practice (EEA Grants) Brief description of declared expenditure Payments to pre-defined project No 3
Previous advance and interim payments
Proposed expenditure for the period
Total to date Total budget Available budget
Version 0.2 as of 14/08/2026 15:02:21 CEST 5
Eligible expenditure € 0.00 € 180,000.00 € 180,000.00 € 2,925,882.35 € 2,745,882.35
Title: Bilateral Outcome: Bilateral funds at programme level Brief description of declared expenditure Bi-lateral initiatives proposals.
Previous advance and interim payments
Proposed expenditure for the period
Total to date Total budget Available budget
Eligible expenditure € 0.00 € 5,000.00 € 5,000.00 € 85,000.00 € 80,000.00
Version 0.2 as of 14/08/2026 15:02:21 CEST 6
Part C - Forecast Allocation
(a)
Estimated absorption rate
(b)
Paid 2025 (c1)
Paid Jan-Jun
2026 (d)
Jul-Dec 2026 (e)
Payment current 2026
(f)=(d)+(e)
Payment 2027 (g)
Payment until the end of the FM
(h)=[(a)-(c)-(f)-(g)]*(b)
Total forecast (i)=(c)+(f)+(g)+(h)
Total by programme € 12,265,000.00 100.00 % € 0.00 € 0.00 € 519,250.00 € 519,250.00 € 1,000,000.00 € 10,745,750.00 € 12,265,000.00 EEA Grants € 12,265,000.00 100.00 % € 0.00 € 0.00 € 519,250.00 € 519,250.00 € 1,000,000.00 € 10,745,750.00 € 12,265,000.00
Version 0.2 as of 14/08/2026 15:02:21 CEST 7
Programme operator Full legal name: Ministry of Social Affairs - Estonia (EE) Programme operator signature I certify that I am duly authorised to sign this interim financial report and that the proposed expenditure described in Part B from which this interim payment is calculated is a realistic estimate of the expenditure that will actually be required by the Programme in the period referred to in Part B. I have thoroughly reviewed the expenditure declared in Part A, and co - financing provided in Part B of this report, and confirm that the information provided is accurate. I confirm that this Programme is carried out as described in the Programme Agreement and that the declared expenditure is correctly represented. Overall implementation status (including milestones): Programme Agreement was signed on May 26, 2026. From there, until the end of the reporting period, i.e. June 30, 2026, mainly preparatory work on management structures and elaborating pre- defined projects for financing has been undertaken. No costs have occurred yet.
Question Answer Comment
Were monitoring and verifications conducted to ensure quality and/or regularity of implementation?
No No audits made yet regarding the management and control systems of the programme.
Are project-level information in Grace updated with the most recent financial data?
N/A No projects financed yet.
Are all the irregularities, their investigation and any remedies taken reported?
N/A No irregularities detected.
Are the special conditions and programme-specific rules set out in the programme agreement fulfilled (Art 5.6.1 (x))?
Yes
A pre-condition that a detailed budget for the pre-defined project, including the role and contribution of any Donor project partner(s) sholud be confirmed by the FMC, was lifted on June 18, 2026.
Do you consider the collaboration with the IPO in its role as IPO at programme level to be working well?
N/A No IPOs engaged at programme level.
Are you aware of any issues affecting the collaboration with the IPO(s) as partner(s) in pre-defined project(s)?
N/A No IPOs engaged at pre-defined projects' level.
For the Programme Operator
Signed in ............................. on ................
...................................................................
Version 0.2 as of 14/08/2026 15:02:21 CEST 8
Version 0.2 as of 14/08/2026 15:02:21 CEST 9
Certification of expenditure declared and co-financing Interim financial report number 1 Start date of declared expenditure period 28/05/2025 End date of declared expenditure period 30/06/2026 Expenditure declared this period € 0.00 Start date of proposed expenditure period 01/01/2027 End date of proposed expenditure period 30/06/2027 Expenditure proposed this period € 610,000.00 Cumulative co-financing reported to date (part A) € 0.00 Cumulative co-financing planned (including proposed amount in part B) € 90,750.00 Interest earned (current reporting period) € 0.00 Total interest earned € 0.00 Interest paid (current reporting period) € 0.00 Total interest paid € 0.00 The Certifying Authority hereby certifies that: - for incurred expenditure and fulfilment of conditions for simplified cost options (SCOs): a. the supporting documents for incurred expenditure and fulfilment of conditions for SCOs have been examined and found to be authentic, correct and accurate; b. payments to projects have been executed as reported; c. co-financing in relation to declared expenditure has been paid; d. when relevant, that the interest to date has been reported in the relevant Interim Financial Reports; e. the expenditure included in the report have been reported within the 12 months of the end of the reporting period in which it should have been declared. - for incurred expenditure: f. the summary of eligible expenditure submitted by the Programme Operator is in full conformity with the supporting documents; g. the summary of eligible expenditure is based on verifiable accounting which is in compliance with generally accepted accounting principles and methods; h. the summary of eligible expenditure falls within eligible expenditure under the Regulation for the implementation of the EEA / Norwegian Financial Mechanisms 2021-2028; i. the summary of expenditure is incurred as part of the implementation of the Programme in accordance with the Programme Agreement; j. sufficient audit trail exists. For the Certifying Authority
Signed in ............................. on ................
...................................................................
| Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
|---|